Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 3524
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
59583
Vested interest in the rigged system. Nuff said.
(2)
AlanC
08/31/2019 8:13:06 AM
59582
https://blog.otcmarkets.com/2018/11/13/understand
(1)
bandg
08/30/2019 10:25:52 PM
59581
FINRA short sales of IPIX
(1)
AlanC
08/30/2019 5:53:47 PM
59580
.14 NICE!! Boogity boogity
BooDog
08/30/2019 10:47:02 AM
59579
Standing by for news. Would be nice to have
(1)
BooDog
08/30/2019 10:39:56 AM
59578
thx alan .. that is interesting to note TGIF ..
(2)
4kids
08/30/2019 10:07:55 AM
59577
4 accounts at Fidelity (Roth and rollover) all
(2)
AlanC
08/30/2019 10:02:08 AM
59576
interesting because that was a subject of my
(2)
4kids
08/30/2019 9:48:13 AM
59574
Today's Swindlers list of bashers IMO. It is
(2)
Kelt
08/30/2019 9:25:26 AM
59573
According to the proxy there were 205,620.200
(3)
AlanC
08/30/2019 9:20:31 AM
59572
always telling *imo* to see how unhinged NR is
(4)
4kids
08/30/2019 9:12:56 AM
59570
IPIX .. 8.29.19 DRS % ..
(3)
4kids
08/30/2019 9:08:09 AM
59569
IPIX .. 8.28.19 DRS % ..
(4)
4kids
08/30/2019 8:37:57 AM
59568
silence can be deafening... and maybe its a
(4)
steelyeye
08/29/2019 9:06:32 PM
59565
very interesting day .. imo curious to see how
(2)
4kids
08/29/2019 7:44:32 PM
59564
FINRA short sales of IPIX
(1)
AlanC
08/29/2019 5:34:52 PM
59560
Looks like NITE says game on. Sneaking shares
(1)
BooDog
08/29/2019 11:19:20 AM
59557
Received a little expose from a large investor.
(4)
Biobum99
08/29/2019 10:02:08 AM
59552
FINRA short sales of IPIX
(4)
AlanC
08/28/2019 5:34:50 PM
59551
We're one good phase 2 Oral Kevetrin trial away
Lemoncat
08/28/2019 4:22:07 PM
59549
Here is a good post on the other site: Lets
(3)
Fit007
08/28/2019 2:05:34 PM
59548
Another one.
(3)
4kids
08/28/2019 2:01:39 PM
59547
Interesting notation from PJ007-thanks to him for
bandg
08/28/2019 1:52:35 PM
59546
Question posted to me: "What stops another
(2)
Biobum99
08/28/2019 1:45:09 PM
59545
I can assure you that this is not the
Lemoncat
08/28/2019 1:30:45 PM
59544
https://pubchem.ncbi.nlm.nih.gov/compound/4-Isoth
bandg
08/28/2019 1:14:46 PM
59543
Another one.
(1)
bandg
08/28/2019 12:50:18 PM
59541
I don't think so. This is an authorized chemical
Biobum99
08/28/2019 11:59:01 AM
59540
https://www.sigmaaldrich.com/catalog/product/sigm
bandg
08/28/2019 11:56:15 AM
59537
I actually have them and a few others on ignore.
BooDog
08/28/2019 11:06:13 AM
59535
edited in .. IPIX *trades* .. and yep one can
(4)
4kids
08/28/2019 10:58:01 AM
59533
this is why volume (real/bogus and in between) ..
(4)
4kids
08/28/2019 10:45:50 AM
59532
Is that who is formulating it?
zdubble17
08/28/2019 10:29:36 AM
59530
Maybe Ill buy in bulk and formulate my own
(1)
Biobum99
08/28/2019 9:08:10 AM
59529
It's also a joke that Scott Smith, Lemoncat and
(1)
Fit007
08/28/2019 8:57:35 AM
59528
IPIX .. 8.27.19 DRS % ..
(3)
4kids
08/28/2019 8:53:28 AM
59527
lemoncat is also on liehub....he goes by Scott
(1)
Fit007
08/28/2019 8:46:35 AM
59526
It seems the change outs are happening more
(8)
4kids
08/28/2019 8:13:38 AM
59523
If you aren't buying when you can and holding
(4)
annakneemuss
08/27/2019 11:03:58 PM
59522
Any body who decides to buy or sell based on an
(4)
Kelt
08/27/2019 10:16:51 PM
59521
Perhaps. Decision is way above my pay
(1)
someconcerns
08/27/2019 7:37:54 PM
59520
I agree with that, some are transparent. And I
(1)
bandg
08/27/2019 7:23:14 PM
59519
BandG, EOTL disliked my post and I need not guess
(2)
someconcerns
08/27/2019 7:12:17 PM
59518
Been verified for a long time. Lemoncat is
(1)
Biobum99
08/27/2019 7:07:20 PM
59517
FINRA short sales of IPIX
(1)
AlanC
08/27/2019 5:36:17 PM
59516
Could be. Just seems like the information might
(1)
bandg
08/27/2019 5:21:12 PM
59515
Kelt, Lemoncat has got to drop to the next level,
(1)
zdubble17
08/27/2019 5:11:55 PM
59514
Publicly showing who likes or dislikes a post
(2)
someconcerns
08/27/2019 5:07:32 PM
59513
Probably the best method that can be done but I
(1)
bandg
08/27/2019 4:56:46 PM
59511
I believe the strong Galera results and their BTD
(1)
Lemoncat
08/27/2019 4:30:14 PM
Newer
Older
Recent Articles
Market Outlook: Job Data Fuels Bond Yields, Impacts Stocks
Ascendis Pharma Unveils Strategic Roadmap for Future Growth
Telix Pharmaceuticals Strengthens Position with Key Acquisition
Innovative Retail Tech Recognized in Upcoming NRF Report
Revvity's Upcoming Earnings Call and Positive Financial Outlook
Vertex Pharmaceuticals Unveils Key Pipeline Developments Ahead of Meetings
Class Action Lawsuit Against Capri Holdings Limited: Join Now
Opportunity for Investors in Caribou Biosciences, Inc. Lawsuit
Enhanced Offer by Bain Capital Targets Insignia Financial's Future
Amicus Therapeutics Announces Unprecedented Revenue Growth
Exelixis Reveals 2024 Financial Performance and 2025 Outlook
Hologic Reports Strong Preliminary Revenues for Q1 of 2025
Alnylam Pharmaceuticals Sets Ambitious Revenue Goals for 2025
BioAge Labs, Inc. Faces Class Action Lawsuit Over Stock Decline
Nextracker Investors Can Join Class Action for Loss Recovery
Blueprint Medicines' Strategies for 2025 Success and Growth
Class Action Lawsuit Opportunity for Regeneron Investors
Capri Holdings Limited Investors Invited to Join Class Action
Chancellor Scholz Addresses Tensions and Defense Spending Risks
Scorpio Tankers Enhances Financial Flexibility with Bonds
Investors Urged to Join Lawsuit Against Celsius Holdings, Inc.
DMC Global Inc. Faces Securities Fraud Allegations from Investors
Mark Cuban Highlights Bitcoin’s Value Amid Economic Challenges
Peter Brandt's Insights on Bitcoin Price Movements Ahead
Transforming Retail Technology: Direct Source at NRF 2025
Molecular Partners Enhances Focus on Radiopharmaceuticals for Future Growth
Expanding Horizons in Cancer Treatment: A New Era for DARPin Therapies
QIAGEN's Strategic Plan: $300 Million Shareholder Return
Innovative Dairy Farming: Transforming Waste into Energy
BlackRock Faces New Deadline from Bank Regulator on Investments
Transforming Retail with VusionGroup: Driving Positive Change
Exagen Inc. Announces New Biomarkers and Financial Success
10x Genomics Reveals Strong Results for FY 2024 Performance
IDEAYA Biosciences Prepares for J.P. Morgan Conference Insights
Israel Uses Collected Taxes to Settle Debt with IEC
Steve Bannon Critiques Elon Musk: A High-Stakes Confrontation
Sebastien Latapie Elevated to Partner Role at AVANT BIO
Ultragenyx Pharmaceutical's Revenue Growth and Future Outlook
Mereo BioPharma's Advancements in Rare Disease Treatments
Recent Trends in Israel's Stock Market: Notable Gains Observed
Important Update for Tungray Technologies (NASDAQ: TRSG) Investors
Dentsply Sirona: Legal Proceedings and Investor Insights Explained
MicroStrategy Increases Bitcoin Holdings Amid Market Changes
RxSight, Inc. Shares Promising Financial Projections for 2025
Pricer and Focal Systems Unite to Transform Retail Experience
JPMorgan Implements Full-Time Office Policy, Sparks Debate
Legal Action Against Customers Bancorp: Investors Should Act Now
Enhancing Retail Security: Shrink Analyzer's New Features
Impact of U.S. Sanctions on Russian Oil Supply Strategies
Timely Opportunity for Investors in Five9, Inc. Securities Case